364 related articles for article (PubMed ID: 34350136)
1. Alopecia Areata: An Autoimmune Disease of Multiple Players.
Suchonwanit P; Kositkuljorn C; Pomsoong C
Immunotargets Ther; 2021; 10():299-312. PubMed ID: 34350136
[TBL] [Abstract][Full Text] [Related]
2. Alopecia areata: autoimmune basis of hair loss.
Alexis AF; Dudda-Subramanya R; Sinha AA
Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata: A multifactorial autoimmune condition.
Simakou T; Butcher JP; Reid S; Henriquez FL
J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
[TBL] [Abstract][Full Text] [Related]
4. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
[TBL] [Abstract][Full Text] [Related]
5. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Zhou C; Li X; Wang C; Zhang J
Clin Rev Allergy Immunol; 2021 Dec; 61(3):403-423. PubMed ID: 34403083
[TBL] [Abstract][Full Text] [Related]
6. The autoimmune basis of alopecia areata: a comprehensive review.
Islam N; Leung PS; Huntley AC; Gershwin ME
Autoimmun Rev; 2015 Feb; 14(2):81-9. PubMed ID: 25315746
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Alopecia Areata.
Afford R; Leung AKC; Lam JM
Curr Pediatr Rev; 2021; 17(1):45-54. PubMed ID: 32351186
[TBL] [Abstract][Full Text] [Related]
8. Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options.
Darwin E; Hirt PA; Fertig R; Doliner B; Delcanto G; Jimenez JJ
Int J Trichology; 2018; 10(2):51-60. PubMed ID: 29769777
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis.
Osman S; Traboulsi D
SAGE Open Med Case Rep; 2023; 11():2050313X231152066. PubMed ID: 36744055
[TBL] [Abstract][Full Text] [Related]
10. Treatment of alopecia areata: An Australian expert consensus statement.
Cranwell WC; Lai VW; Photiou L; Meah N; Wall D; Rathnayake D; Joseph S; Chitreddy V; Gunatheesan S; Sindhu K; Sharma P; Green J; Eisman S; Yip L; Jones L; Sinclair R
Australas J Dermatol; 2019 May; 60(2):163-170. PubMed ID: 30411329
[TBL] [Abstract][Full Text] [Related]
11. Are Preferred Scalp Locations for Alopecia Areata Patches a Clue to Neuronal Etiology?
Juhasz M; Mesinkovska NA
Skin Appendage Disord; 2019 Aug; 5(5):283-287. PubMed ID: 31559251
[TBL] [Abstract][Full Text] [Related]
12. Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.
Paggioli I; Moss J
J Autoimmun; 2022 Dec; 133():102926. PubMed ID: 36335798
[TBL] [Abstract][Full Text] [Related]
13. Effective management Alopecia totalis by Ayurveda - A case report.
Patil SB; Patil GS; Patil V
J Ayurveda Integr Med; 2023; 14(6):100805. PubMed ID: 38043433
[TBL] [Abstract][Full Text] [Related]
14. Thyroid autoimmunity in patients with alopecia areata.
Kasumagić-Halilović E
Acta Dermatovenerol Croat; 2008; 16(3):123-5. PubMed ID: 18812059
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of alopecia areata.
Olayinka JJT; Richmond JM
Curr Res Immunol; 2021; 2():7-11. PubMed ID: 35492401
[TBL] [Abstract][Full Text] [Related]
16. Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata.
Eisman S; Sinclair R
Expert Opin Investig Drugs; 2021 Dec; 30(12):1169-1174. PubMed ID: 34826225
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata: A Review Article.
Rastaghi F; Kaveh R; Yazdanpanah N; Sahaf AS; Ahramyanpour N
Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992355
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.
Kennedy Crispin M; Ko JM; Craiglow BG; Li S; Shankar G; Urban JR; Chen JC; Cerise JE; Jabbari A; Winge MC; Marinkovich MP; Christiano AM; Oro AE; King BA
JCI Insight; 2016 Sep; 1(15):e89776. PubMed ID: 27699252
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
